Na+, K+, and Ca2+ Channel Blocker Drugs Flashcards Preview

CRRAB--Wk 4 > Na+, K+, and Ca2+ Channel Blocker Drugs > Flashcards

Flashcards in Na+, K+, and Ca2+ Channel Blocker Drugs Deck (22)
Loading flashcards...
1
Q

Amiodarone

A

MOA/Cardiac Effects: K+ channel blocker, prolonging effective refractory period (prolongs QT interval)

Extracardiac Effects: peripheral vasodilation

Toxicity: bradycardia, heart block in pts with pre-existing nodal disease, source of inorganic iodine (screws up thyroid)

PK: dose-related pulmonary toxicty, CYP3A4 hepatic metabolism

TU: reentry arrhythmias

2
Q

Dofetilide

A

MOA/Cardiac Effects: selective K+ channel blocker, prolongs effective refractory period (prolonging QT) primarily in ventricles

Extracardiac Effects:

Toxicity: lethal ventricular arrhythmias

PK: CYP3A4 hepatic metabolism

TU: a-fib, contraindicated in prolonged QT, bradycardia, hypokalemia

3
Q

Ibutilide

A

MOA/Cardiac Effects: K+ channel blocker (prolonging QT and refractory period), also Na+ channel blocker (slows depolarization)

Extracardiac Effects:

Toxicity: torsade de pointes

PK: hepatic metabolism

TU: a-fib and a-flutter, 20 min to effect

4
Q

“pine”s

A

MOA/Cardiac Effects: dihydropyridine Ca2+ channel blocker, effects primarily sm. muscle tissue causing relaxation

Extracardiac Effects: vascular sm. muscle relaxation

Toxicity: reflex tachycardia

PK:

TU: HTN

5
Q

Verapamil

A

MOA/Cardiac Effects: non-dihydropyridine L-type Ca2+ blocker, prolongs AP in nodal cells –> decrease HR

Extracardiac Effects: peripheral vasodilation (minimal)

Toxicity: AV node block, constipation, peripheral edema

PK: hepatic metabolism

TU: supraventricular tachycardia, a-fib and a-flutter, contradicted in Wolf-Parkinson-White (accessory pathway)

6
Q

Diltiazem

A

MOA/Cardiac Effects: non-selective L-type Ca2+ channel blocker, nodal cells (decrease HR) and vascular sm. muscle (vasodilation)

Extracardiac Effects: sm. muscle (vasodilation)

Toxicity: hypotension

PK: hepatic metabolism

TU: supraventricular tachycardia, a-fib, a-flutter, contradicted in Wolf-Parkinson-White syndrome (accessory pathway)

7
Q

Adenosine

A

MOA/Cardiac Effects: activation of K+ channels and inhibition of L-type Ca2+ channels. hyperpolarization of cells and suppression of Ca2+-dependent nodal tissue

Extracardiac Effects:

Toxicity: hypotension, a-fib, headache

PK: 10 second half life

TU: supraventricular tachycardia

8
Q

Digitalis

A

MOA/Cardiac Effects: inhibits Na+/K+ ATPase pump, indirectly inhibiting Na+/Ca2+ antiporter

contractile cells: more Ca2+ = positive inoptrope

vagal activation = negative chronotrope

Extracardiac Effects:

Toxicity: arrhythmias

PK:

TU: refractory CHF

9
Q

Procainamine

A

MOA/Cardiac Effects: IA Na+ channel blocker, slows AP upstroke, prolonges QRS, prolonges action potential depolarization through non-specific blocking of K+ channels

Extracardiac Effects: hypotension from reduced peripheral vascular resistance

Toxicity: torsade, lupus-like syndrome in long-term

PK: hepatic metabolism, renal excretion

TU: atrial and ventricular arrhythmias

10
Q

Quinidine

A

MOA/Cardiac Effects: IA Na+ channel blocker, prolongs QRS, prolongs action potential by non-specific K+ channel blockade

Extracardiac Effects: GI effects, cinchonism (headache, dizziness, tinnitus)

Toxicity: QT prolongation, torsade, arrhythmias, sycope

PK: hepatic metabolism, renal excretion

TU: rarely used

11
Q

Disopyramide

A

MOA/Cardiac Effects: IA Na+ channel blocker, prolongs QRS, blocks action potential depolarization through non-specific K+ channel blockade

Extracardiac Effects: atropine-like activity

Toxicity: heart failure

PK: loading dose not recommended

TU: ventricular arrhythmias

12
Q

Lidocaine

A

MOA/Cardiac Effects: IB Na+ channel blocker, selective depression of conduction in depolarized cells, little effect seen on EKG

Extracardiac Effects:

Toxicity: neurologic

PK: IV only, t1/2 = 1-2 hr

TU: v-tach after cardioversion in acute ischemia

13
Q

Mexiletine

A

MOA/Cardiac Effects: IB Na+ channel blocker, orally active version of lidocaine, selective depression of conduction in depolarized cells, little effect seen on EKG

Extracardiac Effects:

Toxicity: neurologic

PK: PO

TU: diabetic neuropathy (off label)

14
Q

Tocainide

A

MOA/Cardiac Effects: lidocaine analogue, no longer sold in USA

Extracardiac Effects:

Toxicity:

PK:

TU:

15
Q

Flecainide

A

MOA/Cardiac Effects: IC Na+ channel blocker, slows AP upstroke, prolongs refractory period in AV node

Extracardiac Effects:

Toxicity:

PK:

TU: supraventricular tachycardias incl. a-fib, refractory v-tach last resort

16
Q

Propafenone

A

MOA/Cardiac Effects: IC Na+ channel blocker, slows AP upstroke,

Extracardiac Effects:

Toxicity: pro-arrhythmatic post-MI

PK:

TU: supraventricular tachycardias incl. a-fib

17
Q

Moricizine

A

MOA/Cardiac Effects: IC Na+ channel blocker, no longer available

Extracardiac Effects:

Toxicity:

PK:

TU:

18
Q

Propanolol

A

MOA/Cardiac Effects: nonspecific β1 and β2 antagonist

Extracardiac Effects:

Toxicity:

PK:

TU:

19
Q

Metoprolol

A

MOA/Cardiac Effects: β1 antagonist

Extracardiac Effects:

Toxicity:

PK:

TU:

20
Q

Acebutolol

A

MOA/Cardiac Effects: β1 antagonist

Extracardiac Effects:

Toxicity:

PK:

TU:

21
Q

Esmolol

A

MOA/Cardiac Effects: β1 antagonist

Extracardiac Effects:

Toxicity:

PK:

TU:

22
Q

Sotalol

A

MOA/Cardiac Effects: β1 antagonist

Extracardiac Effects:

Toxicity:

PK:

TU: